Surrogate markers of effective anti-tumor immunity.
Publication
, Other
Lyerly, HK; Morse, MA; Clay, TM
Published in: Ann Surg Oncol
April 2001
Duke Scholars
Published In
Ann Surg Oncol
DOI
ISSN
1068-9265
Publication Date
April 2001
Volume
8
Issue
3
Start / End Page
190 / 191
Location
United States
Related Subject Headings
- Prognosis
- Oncology & Carcinogenesis
- Neoplasms
- Immunotherapy
- Humans
- Cancer Vaccines
- Biomarkers
- Antigens, Neoplasm
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyerly, H. K., Morse, M. A., & Clay, T. M. (2001). Surrogate markers of effective anti-tumor immunity. Ann Surg Oncol. United States. https://doi.org/10.1007/s10434-001-0190-6
Lyerly, H. K., M. A. Morse, and T. M. Clay. “Surrogate markers of effective anti-tumor immunity.” Ann Surg Oncol, April 2001. https://doi.org/10.1007/s10434-001-0190-6.
Lyerly HK, Morse MA, Clay TM. Surrogate markers of effective anti-tumor immunity. Vol. 8, Ann Surg Oncol. 2001. p. 190–1.
Lyerly, H. K., et al. “Surrogate markers of effective anti-tumor immunity.” Ann Surg Oncol, vol. 8, no. 3, Apr. 2001, pp. 190–91. Pubmed, doi:10.1007/s10434-001-0190-6.
Lyerly HK, Morse MA, Clay TM. Surrogate markers of effective anti-tumor immunity. Ann Surg Oncol. 2001. p. 190–191.
Published In
Ann Surg Oncol
DOI
ISSN
1068-9265
Publication Date
April 2001
Volume
8
Issue
3
Start / End Page
190 / 191
Location
United States
Related Subject Headings
- Prognosis
- Oncology & Carcinogenesis
- Neoplasms
- Immunotherapy
- Humans
- Cancer Vaccines
- Biomarkers
- Antigens, Neoplasm
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis